Variants in mitochondrial disease genes are common causes of inherited peripheral neuropathies
- PMID: 38549004
- PMCID: PMC11136726
- DOI: 10.1007/s00415-024-12319-y
Variants in mitochondrial disease genes are common causes of inherited peripheral neuropathies
Abstract
Background: Peripheral neuropathies in mitochondrial disease are caused by mutations in nuclear genes encoding mitochondrial proteins, or in the mitochondrial genome. Whole exome or genome sequencing enable parallel testing of nuclear and mtDNA genes, and it has significantly advanced the genetic diagnosis of inherited diseases. Despite this, approximately 40% of all Charcot-Marie-Tooth (CMT) cases remain undiagnosed.
Methods: The genome-phenome analysis platform (GPAP) in RD-Connect was utilised to create a cohort of 2087 patients with at least one Human Phenotype Ontology (HPO) term suggestive of a peripheral neuropathy, from a total of 10,935 patients. These patients' genetic data were then analysed and searched for variants in known mitochondrial disease genes.
Results: A total of 1,379 rare variants were identified, 44 of which were included in this study as either reported pathogenic or likely causative in 42 patients from 36 families. The most common genes found to be likely causative for an autosomal dominant neuropathy were GDAP1 and GARS1. We also detected heterozygous likely pathogenic variants in DNA2, MFN2, DNM2, PDHA1, SDHA, and UCHL1. Biallelic variants in SACS, SPG7, GDAP1, C12orf65, UCHL1, NDUFS6, ETFDH and DARS2 and variants in the mitochondrial DNA (mtDNA)-encoded MT-ATP6 and MT-TK were also causative for mitochondrial CMT. Only 50% of these variants were already reported as solved in GPAP.
Conclusion: Variants in mitochondrial disease genes are frequent in patients with inherited peripheral neuropathies. Due to the clinical overlap between mitochondrial disease and CMT, agnostic exome or genome sequencing have better diagnostic yields than targeted gene panels.
Keywords: CMT; Genetic heterogeneity; Genome-phenome analysis platform (GPAP); Mitochondrial disease; Peripheral neuropathies; Rare variants.
© 2024. The Author(s).
Conflict of interest statement
The authors have no financial or non-financial interest that are directly or indirectly related to the work submitted for publication.
Figures
References
-
- Horvath R, Medina J, Reilly MM, Shy ME, Zuchner S (2023) Peripheral neuropathy in mitochondrial disease. Handbook of clinical neurology. 194: Elsevier, p. 99–116. - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
- 950-232279/Canada Research Chairs
- Research Grant 2019/Lily Foundation
- G117372/Evelyn Trust
- Research Grant 2022/Action for A-T
- 109915/Z/15/Z/WT_/Wellcome Trust/United Kingdom
- FDN-167281/CIHR
- BRC-1215-20014/NIHR Cambridge Biomedical Research Centre
- ERT-174211/Transnational Team Grant
- WT_/Wellcome Trust/United Kingdom
- MR/S005021/1/MRC_/Medical Research Council/United Kingdom
- PhD fellowship/Muscular Dystrophy UK
- MR/V009346/1/MRC_/Medical Research Council/United Kingdom
- G100142/Addenbrooke's Charitable Trust, Cambridge University Hospitals
- OR2-189333 (NMD4C)/Canada Foundation for Innovation
- MFE-491707/Canadian Institute for Health Research
- NFRFG-2022-00033/Canada Research Coordinating Committee
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
